Skip to main content
. 2021 May 6;6(2):71. doi: 10.3390/tropicalmed6020071

Figure 2.

Figure 2

Cascade of blood culture positivity, isolate identification, and AST among hospitalized, non-malarial febrile patients undergoing blood culture at the five AMR surveillance sites in Uganda, October 2017–September 2018. a One BC specimen bottle collected from each child; b Performance target for BCC rates range from 2–3%; c Performance target for BC diagnsotic yield range from 6–12%. Only one isolate per specimen was included in our analysis; d Performance target for Gram-staining and reporting for all specimens showing clinically significant growth is 100%; e Performance target for pathogen identification and reporting is 100%; f Performance target for AST and reporting for all identified pathogens is 100%; g AST data for all AMR priority pathogens should be reported to clinicians and transmitted to the AMR NCC.